Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3 - Rachel Ochs-Ross, Ella J. Daly, Yun Zhang, Rosanne Lane, Pilar Lim, Randall L. Morrison, David Hough, Husseini Manji, Wayne C. Drevets, Gerard Sanacora, David C. Steffens, Caleb Adler, Rupert McShane, Raphaël Gaillard, Samuel T. Wilkinson - Dissemin

Language
Login

Published in

Elsevier, American Journal of Geriatric Psychiatry, 2(28), p. 121-141, 2020

DOI: 10.1016/j.jagp.2019.10.008

Links

Elsevier

Tools

Export citation

Search in Google Scholar

Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3

Journal article published in 2019 by Rachel Ochs-Ross, Ella J. Daly, Yun Zhang, Rosanne Lane, Pilar Lim, Randall L. Morrison, David Hough, Husseini Manji, Wayne C. Drevets, Gerard Sanacora, David C. Steffens, Caleb Adler, Rupert McShane, Raphaël Gaillard, Samuel T. Wilkinson and other authors.

This paper is made freely available by the publisher.

This paper is made freely available by the publisher.

Full text: Download

Green circle

Preprint: archiving allowed

Upload

Orange circle

Postprint: archiving restricted

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO